{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:57:46Z","timestamp":1780405066300,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008302","name":"Department of Education and Learning Northern Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008302","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00125-016-4108-z","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T06:16:34Z","timestamp":1474956994000},"page":"2674-2685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice"],"prefix":"10.1007","volume":"59","author":[{"given":"Aine M.","family":"McKillop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser H. A.","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noella M.","family":"Gormley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"4108_CR1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/14728222.11.5.661","volume":"11","author":"GV Rayasam","year":"2007","unstructured":"Rayasam GV, Tulasi VK, Davis JA, Bansal VS (2007) Fatty acid receptors as new therapeutic targets for diabetes. Expert Opin Ther Targets 11:661\u2013671","journal-title":"Expert Opin Ther Targets"},{"key":"4108_CR2","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.2174\/09298673113209990168","volume":"20","author":"T Yonezawa","year":"2013","unstructured":"Yonezawa T, Kurata R, Yoshida K, Murayama MA, Cui X, Hasegawa A (2013) Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics. Curr Med Chem 20:3855\u20133871","journal-title":"Curr Med Chem"},{"key":"4108_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00592-015-0826-9","volume":"53","author":"BM Moran","year":"2016","unstructured":"Moran BM, Flatt PR, McKillop AM (2016) G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis. Acta Diabetol 53:177\u2013188","journal-title":"Acta Diabetol"},{"key":"4108_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/2042018810375656","volume":"1","author":"V Vangaveti","year":"2010","unstructured":"Vangaveti V, Shashidhar V, Jarrod G, Baune BT, Kennedy RL (2010) Free fatty acid receptors: emerging targets for treatment of diabetes and its complications. Ther Adv Endocrinol Metab 1:165\u2013175","journal-title":"Ther Adv Endocrinol Metab"},{"key":"4108_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","volume":"89","author":"G Godlewski","year":"2009","unstructured":"Godlewski G, Offertaler L, Wagner JA, Kunos G (2009) Receptors for acylethanolamides- GPR55 and GPR119. Prostaglandins Other Lipid Mediat 89:105\u2013111","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4108_CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/en.2010-1047","volume":"152","author":"G Flock","year":"2011","unstructured":"Flock G, Holland D, Seino Y, Drucker DJ (2011) GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Endocrinology 152:374\u2013383","journal-title":"Endocrinology"},{"key":"4108_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153\u2013165","journal-title":"Cell Metab"},{"key":"4108_CR8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/physrev.00013.2014","volume":"95","author":"DA Sandoval","year":"2015","unstructured":"Sandoval DA, D\u02bcAlessio DA (2015) Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev 95:513\u2013548","journal-title":"Physiol Rev"},{"key":"4108_CR9","doi-asserted-by":"crossref","unstructured":"Moran BM, Abdel-Wahab YH, Flatt PR, McKillop AM (2014) Activation of GPR119 by fatty acid agonists augments insulin release from clonal \u03b2-cells and isolated pancreatic islets and improves glucose tolerance in mice. Biol Chem 395:453\u2013464","DOI":"10.1515\/hsz-2013-0255"},{"key":"4108_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2010.08.097","volume":"400","author":"S Yoshida","year":"2010","unstructured":"Yoshida S, Ohishi T, Matsui T, Shibasaki M (2010) Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun 400:437\u2013441","journal-title":"Biochem Biophys Res Commun"},{"key":"4108_CR11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1210\/me.2013-1029","volume":"27","author":"OG Chepurny","year":"2013","unstructured":"Chepurny OG, Bertinetti D, Diskar M et al (2013) Stimulation of proglucagon gene expression by human GPR119 in enterendocrine L-cell line GLUTag. Mol Endocrinol 27:1267\u20131282","journal-title":"Mol Endocrinol"},{"key":"4108_CR12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1432-2277.2011.01332.x","volume":"24","author":"J Gao","year":"2011","unstructured":"Gao J, Tian L, Weng G et al (2011) Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl Int 24:1124\u20131134","journal-title":"Transpl Int"},{"key":"4108_CR13","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/db08-1237","volume":"58","author":"LM Lauffer","year":"2009","unstructured":"Lauffer LM, Iakoubov R, Brubaker PL (2009) GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cells. Diabetes 58:1058\u20131066","journal-title":"Diabetes"},{"key":"4108_CR14","doi-asserted-by":"crossref","first-page":"e53345","DOI":"10.1371\/journal.pone.0053345","volume":"8","author":"LY Ansarullah","year":"2013","unstructured":"Ansarullah LY, Holstein M, DeRuyter B, Rabinovitch A, Guo Z (2013) Stimulating \u03b2-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor. PLoS One 8:e53345","journal-title":"PLoS One"},{"key":"4108_CR15","doi-asserted-by":"crossref","first-page":"e63861","DOI":"10.1371\/journal.pone.0063861","volume":"8","author":"M Zhang","year":"2013","unstructured":"Zhang M, Feng Y, Wang J et al (2013) High throughput screening for GPR119 modulators identifies a novel compound with anti-diabetic efficacy in db\/db mice. PLoS One 8:e63861","journal-title":"PLoS One"},{"key":"4108_CR16","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","volume":"284","author":"A Kapur","year":"2009","unstructured":"Kapur A, Zhao P, Sharir H et al (2009) Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284:29817\u201329827","journal-title":"J Biol Chem"},{"key":"4108_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/JOE-11-0166","volume":"211","author":"SY Romero-Zerbo","year":"2011","unstructured":"Romero-Zerbo SY, Rafacho A, Diaz-Arteaga A et al (2011) A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. J Endocrinol 211:177\u2013185","journal-title":"J Endocrinol"},{"key":"4108_CR18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2982.2011.01742.x","volume":"23","author":"XH Lin","year":"2011","unstructured":"Lin XH, Yuece B, Li YY et al (2011) A novel CB receptor GPR55 and its ligands are involved in regulation of gut movements in rodents. Neurogastroenterol Motil 23:862\u2013871","journal-title":"Neurogastroenterol Motil"},{"key":"4108_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","volume":"139","author":"PC Staton","year":"2008","unstructured":"Staton PC, Hatcher JP, Walker DJ et al (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139:225\u2013236","journal-title":"Pain"},{"key":"4108_CR20","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","volume":"106","author":"LS Whyte","year":"2009","unstructured":"Whyte LS, Ryberg E, Sims NA et al (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106:16511\u201316516","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4108_CR21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","volume":"170","author":"AM McKillop","year":"2013","unstructured":"McKillop AM, Moran BM, Abdel-Wahab YHA, Flatt PR (2013) Evaluation of insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta cells, isolated pancreatic islets and mice. Br J Pharmacol 170:978\u2013990","journal-title":"Br J Pharmacol"},{"key":"4108_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2014.06.007","volume":"145","author":"B Liu","year":"2015","unstructured":"Liu B, Song S, Jones PM, Persaud SJ (2015) GPR55: from orphan to metabolic regulator? Pharmacol Ther 145:35\u201342","journal-title":"Pharmacol Ther"},{"key":"4108_CR23","doi-asserted-by":"crossref","unstructured":"Meadows A, Lee JH, Wu CS et al (2016) Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. Int J Obes (Lond) 40:417\u2013424","DOI":"10.1038\/ijo.2015.209"},{"key":"4108_CR24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577\u20131579","journal-title":"Br J Pharmacol"},{"key":"4108_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","volume":"20","author":"PR Flatt","year":"1981","unstructured":"Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice. Diabetologia 20:573\u2013577","journal-title":"Diabetologia"},{"key":"4108_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-015-0781-5","volume":"53","author":"BM Moran","year":"2016","unstructured":"Moran BM, Abdel-Wahab YH, Vasu S, Flatt PR, McKillop AM (2016) GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis. Acta Diabetol 53:279\u2013293","journal-title":"Acta Diabetol"},{"key":"4108_CR27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s001250050009","volume":"43","author":"P Ohly","year":"2000","unstructured":"Ohly P, Dohle C, Abel J, Seissler J, Gleichmann H (2000) Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43:1020\u20131030","journal-title":"Diabetologia"},{"key":"4108_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/jpet.110.176396","volume":"337","author":"Y Ning","year":"2011","unstructured":"Ning Y, Zhen W, Fu Z et al (2011) Ranolazine increases \u03b2-cell survival and improves glucose homeostasis in low-dose streptozotocin-induced diabetes in mice. J Pharmacol Exp Ther 337:50\u201358","journal-title":"J Pharmacol Exp Ther"},{"key":"4108_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/db11-0649","volume":"61","author":"JM Moreno-Navarrete","year":"2012","unstructured":"Moreno-Navarrete JM, Catal\u00e1n V, Whyte L et al (2012) The L-\u03b1-lysophosphatidylinositol\/GPR55 system and its potential role in human obesity. Diabetes 61:281\u2013291","journal-title":"Diabetes"},{"key":"4108_CR30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbrc.2010.08.141","volume":"400","author":"S Yoshida","year":"2010","unstructured":"Yoshida S, Tanaka H, Oshima H et al (2010) AS1907417, a novel GPR119 agonist, as an insulinotropic and \u03b2-cell preservative agent for the treatment of type 2 diabetes. Biochem Biophys Res Commun 400:745\u2013751","journal-title":"Biochem Biophys Res Commun"},{"key":"4108_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bone.2013.07.003","volume":"56","author":"A Mieczkowska","year":"2013","unstructured":"Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G (2013) Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality. Bone 56:337\u2013342","journal-title":"Bone"},{"key":"4108_CR32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/JOE-13-0146","volume":"219","author":"G Mabilleau","year":"2013","unstructured":"Mabilleau G, Mieczkowska A, Irwin N, Flatt PR, Chappard D (2013) Optimal bone mechanical and material properties require a functional GLP-1 receptor. J Endocrinol 219:59\u201368","journal-title":"J Endocrinol"},{"key":"4108_CR33","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/en.2007-0966","volume":"149","author":"ZL Chu","year":"2008","unstructured":"Chu ZL, Carroll C, Alfonso J et al (2008) A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149:2038\u20132047","journal-title":"Endocrinology"},{"key":"4108_CR34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/me.2015-1306","volume":"30","author":"OG Chepurny","year":"2016","unstructured":"Chepurny OG, Holz GG, Roe MW, Leech CA (2016) GPR119 agonist AS1269574 activates TRPA1 cation channels to stimulate GLP-1 secretion. Mol Endocrinol 30:614\u2013629","journal-title":"Mol Endocrinol"},{"key":"4108_CR35","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.2337\/dc11-s230","volume":"34","author":"AJ Garber","year":"2011","unstructured":"Garber AJ (2011) Incretin effects on \u03b2-cell function, replication, and mass. Diabetes Care 34:S258\u2013S263","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4108-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:47:05Z","timestamp":1498333625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4108-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["4108"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4108-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]}}}